114 related articles for article (PubMed ID: 15789822)
1. Child overdose: the value of the French pharmacovigilance causality assessment method.
Rajab M; Lagier G; Eftekhari P; Ginisty S; Bazire A; Garnier R
Therapie; 2004; 59(6):603-6. PubMed ID: 15789822
[TBL] [Abstract][Full Text] [Related]
2. Updating the French method for the causality assessment of adverse drug reactions.
Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
[TBL] [Abstract][Full Text] [Related]
3. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.
Beyens MN; Guy C; Mounier G; Laporte S; Ollagnier M
Drug Saf; 2008; 31(11):1017-26. PubMed ID: 18840021
[TBL] [Abstract][Full Text] [Related]
4. Italian monitoring registries: a tool for a safer use of innovative drugs? Data from the national pharmacovigilance system.
Magro L; Arzenton E; Moretti U; Sottosanti L; Potenza S; Leone R
Expert Opin Drug Saf; 2016 Dec; 15(sup2):69-75. PubMed ID: 27875920
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
6. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
[TBL] [Abstract][Full Text] [Related]
7. [Informativity of French web forums for the evaluation of side effects of baclofen].
Karapetiantz P; Lillo-Le Louët A; Bousquet C
Therapie; 2019 Dec; 74(6):569-578. PubMed ID: 31253414
[TBL] [Abstract][Full Text] [Related]
8. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
[TBL] [Abstract][Full Text] [Related]
9. [Organization and results of drug vigilance in France].
Bégaud B; Chaslerie A; Haramburu F
Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
[TBL] [Abstract][Full Text] [Related]
10. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
[TBL] [Abstract][Full Text] [Related]
11. Adverse drug reactions: physicians' opinions versus a causality assessment method.
Miremont G; Haramburu F; Bégaud B; Péré JC; Dangoumau J
Eur J Clin Pharmacol; 1994; 46(4):285-9. PubMed ID: 7957509
[TBL] [Abstract][Full Text] [Related]
12. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
13. Evaluating Twitter as a complementary data source for pharmacovigilance.
Lardon J; Bellet F; Aboukhamis R; Asfari H; Souvignet J; Jaulent MC; Beyens MN; Lillo-LeLouët A; Bousquet C
Expert Opin Drug Saf; 2018 Aug; 17(8):763-774. PubMed ID: 29991282
[TBL] [Abstract][Full Text] [Related]
14. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
Koh Y; Yap CW; Li SC
Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
[TBL] [Abstract][Full Text] [Related]
15. Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.
Théophile H; Dutertre JP; Gérardin M; Valnet-Rabier MB; Bidault I; Guy C; Haramburu F; Hillaire-Buys D; Méglio C; Arimone Y
Therapie; 2015; 70(5):465-76. PubMed ID: 26423144
[TBL] [Abstract][Full Text] [Related]
16. Causality assessment in pharmacovigilance: The French method and its successive updates.
Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
[TBL] [Abstract][Full Text] [Related]
17. A new method for assessing drug causation provided agreement with experts' judgment.
Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Molimard M; Moore N; Haramburu F
J Clin Epidemiol; 2006 Mar; 59(3):308-14. PubMed ID: 16488362
[TBL] [Abstract][Full Text] [Related]
18. Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey.
Bernard N; Jantzem H; Becker M; Pecriaux C; Bénard-Laribière A; Montastruc JL; Descotes J; Vial T;
BJOG; 2015 Aug; 122(9):1244-51. PubMed ID: 25761676
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.
Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
Fundam Clin Pharmacol; 2014 Apr; 28(2):230-5. PubMed ID: 23190210
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
